These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14781660)

  • 1. Use of alidase in prevention of painful arm in accidental perivascular injection of neoarsphenamine and mapharsen.
    HAIRE RD
    Rocky Mt Med J; 1950 Aug; 47(8):600-1. PubMed ID: 14781660
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the influences of mapharsen on fixed neoarsphenamine eruptions; preliminary report.
    ABE M
    Tohoku J Exp Med; 1950 May; 52(1-2):48. PubMed ID: 14776730
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arsenuria and its variations during injections of progressive doses of novarsenobenzol].
    MERKLEN FP; BERTAUX P
    C R Seances Soc Biol Fil; 1948 Mar; 142(5-6):313-5. PubMed ID: 18878669
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes undergone by phenylarsenious acid and phenylarsonic acid in the animal body.
    Crawford TB; Levvy GA
    Biochem J; 1947; 41(3):333-6. PubMed ID: 16748168
    [No Abstract]   [Full Text] [Related]  

  • 5. Accidental intra-arterial injection of oxophenarsine hydrochloride (mapharsen).
    WALSH EN; WYATT JL
    J Am Med Assoc; 1945 Dec; 129():1255. PubMed ID: 21006172
    [No Abstract]   [Full Text] [Related]  

  • 6. A sterility test for neoarsphenamine B.P. and sulpharsphenamine B.P. for injection.
    SYKES G; ROYCE A; HUGO WB
    J Pharm Pharmacol; 1952 Jun; 4(6):366-72. PubMed ID: 14946682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies of the effect of hyaluronidase on the histologic action of salvarsan].
    FRIDERICH H; KORTING GW
    Arch Dermatol Syph; 1951; 192(5):454-67. PubMed ID: 14838602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Curious case of sudden death occurring at the initial injection of neoarsphenamine].
    BARROS Jde O
    Gaz Med Port; 1954; 7(2):373-6. PubMed ID: 13221020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Novocaine injections with hyaluronidase in the treatment of painful coxalgies].
    BAUMGARTNER P
    Gaz Med Fr; 1953 Mar; 60(6):371-2. PubMed ID: 13060589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hyaluronidase on the trypanocidal action of salvarsan].
    KORTING GW; FRIDERICH HH
    Arch Dermatol Syph; 1951; 193(1):63-7. PubMed ID: 14878461
    [No Abstract]   [Full Text] [Related]  

  • 11. TROPICAL DISEASES OF THE EYE.
    CAHILL KM
    N Y State J Med; 1964 Feb; 64():535-9. PubMed ID: 14125413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resorption and excretion of spirotrypan, a new antiluetic of arsphenamine group].
    HERMANN W; THER L
    Arch Dermatol Syph; 1953; 195(6):670-85. PubMed ID: 13105301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of arsphenamine and arsenoxide on prothrombin time].
    CARNUCCIO S
    Sem Med; 1951 Feb; 58(7):226-9. PubMed ID: 14817428
    [No Abstract]   [Full Text] [Related]  

  • 14. The intensive treatment of early syphilis: in 9 to 15 weeks with triweekly injections of mapharsen (oxophenarsine hydrochloride) and concomitant weekly injections of bismuth: an analysis of the results in 110 cases.
    DEXTER DD
    Am J Syph Gonorrhea Vener Dis; 1947 Sep; 31(5):533-41. PubMed ID: 20262385
    [No Abstract]   [Full Text] [Related]  

  • 15. INVESTIGATIONS INTO THE ETIOLOGY OF DERMATITIS HERPETIFORMIS. II. THE EFFECTS OF SERUM FROM DERMATITIS HERPETIFORMIS CASES AND OF CERTAIN DRUGS ON THE VISCOSITY REDUCTION PROPERTY OF HYALURONIDASE.
    ALEXANDER JO
    J Invest Dermatol; 1965 Aug; 45():73-7. PubMed ID: 14332642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin therapy with alidase in multiple injections: Sacerodoti-Yagdjoglou method].
    VOYER V; RACINE R; WATERKEYN M
    Union Med Can; 1957 Aug; 86(8):861-5. PubMed ID: 13456026
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the physico-chemical properties of arsphenamine and neoarsphenamine.
    MUIC N; FLES D
    Acta Med Iugosl; 1951; 5(3):265-81. PubMed ID: 14877493
    [No Abstract]   [Full Text] [Related]  

  • 18. "A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis"-a commentary.
    Pentapati KC; Gadicherla S; Smriti K
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):784. PubMed ID: 27720658
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of neoarsphenamine erythroderma with penicillin and dimercaprol].
    BONSEL
    Dermatologica; 1948; 96(6):435. PubMed ID: 18893681
    [No Abstract]   [Full Text] [Related]  

  • 20. [TOPICAL TREATMENT OF SOME PHARYNGEAL LESIONS WITH NEOARSPHENAMINE (COLLUNOVAR-ATOMISEUR)].
    TERRIER G
    Ther Umsch; 1964 Jul; 21():272-4. PubMed ID: 14248098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.